In hypertension, a reduction of NO-dependent vasodilation is partially attributed to decreased soluble guanylyl cyclase (sGC) protein levels that are recognized as a key NO receptor in the vascular wall of blood vessels (Rippe et al., 2017). This evidence concerns the gene SGCB and Hypertension.